Kennedy ends federal mRNA vaccine projects over experts objections
Breitbart4 days
This decision is a necessary course correction based on scientific evidence. The data clearly shows that mRNA vaccines don't provide adequate protection against respiratory infections, and they become ineffective when viruses mutate. It's time to invest in proven, safer vaccine platforms that offer broader protection.
Canceling these contracts undermines pandemic preparedness and abandons one of America's most promising medical tools. mRNA technology saved millions of lives during COVID-19 and offers rapid vaccine development crucial for future pandemics. This move weakens defense against biological threats.
There'sThis is a 40%long-overdue chancereckoning thatwith the FDAfailures willof approvepublic ahealth seasonalofficials influenzaand vaccinetheir forties to Big Pharma. For years, the 2025-2026government flupushed seasonmRNA beforeshots Octdespite poor efficacy and growing safety concerns. 1Speed, 2025profit, accordingand tocontrol were prioritized over transparency and caution. This move quietly admits what critics have said all along: the Metaculuspublic predictionwas communitymisled.
There's a 40% chance that the FDA will approve a seasonal influenza vaccine for the 2025-2026 flu season before Oct. 1, 2025, according to the Metaculus prediction community.